Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development
07 déc. 2021 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
Predictive Oncology Acquires zPREDICTA, Inc.
01 déc. 2021 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
Predictive Oncology Reports Third Quarter Financial Results
10 nov. 2021 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results...
Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements
19 oct. 2021 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive...
Predictive Oncology Inc. Announces Newest Board Member
15 sept. 2021 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting
18 août 2021 13h45 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Reports Financial Results for Quarter Ended June 30, 2021, and Provides Business Update
11 août 2021 17h15 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Adjourns Special Meeting of Stockholders
11 août 2021 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes
03 août 2021 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Inc.’s Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs
22 juin 2021 08h30 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, June 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries,...